Steve Kelly and the other panelists discuss their paper titled “Assessing the policy and access environment across European countries for SMA patients.”
For more information on this event, click here.
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Steve Kelly and the other panelists discuss their paper titled “Assessing the policy and access environment across European countries for SMA patients.”
For more information on this event, click here.
Focusing on the intersection of academic research and litigation matters, Daniel Shack and Annabelle Fowler highlight key research developments and discussion...
US policy has long recognized this challenge, beginning with the Orphan Drug Act of 1983 and continuing with recent exemptions for certain orphan indications...